Picture of Jeonjin Bio Co logo

110020 Jeonjin Bio Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapMomentum Trap

Annual income statement for Jeonjin Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,3843,9493,8673,2147,794
Cost of Revenue
Gross Profit1332,0872,2161,3631,965
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses4,5585,9076,0326,24410,888
Operating Profit-3,174-1,958-2,166-3,030-3,094
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-3,399-1,462-3,418-2,108-3,154
Provision for Income Taxes
Net Income After Taxes-3,399-1,462-3,418-2,108-3,154
Net Income Before Extraordinary Items
Net Income-3,399-1,462-3,418-2,108-3,154
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-3,399-1,462-3,418-2,108-3,154
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-707-284-639-340-492
Dividends per Share